Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: J Immunol. 2008 Jun 1;180(11):7471–7479. doi: 10.4049/jimmunol.180.11.7471

Table 1.

Clinical disease traits following immunization of mice with MOG35–55-CFA plus PTX (A) or 2× MOG35–55-CFA (B)

(a)
Strain Incidence DO CDS SI PS
C57BL/6J 19/19 13.1±0.3 56.2±4.6 3.1±0.2 3.9±0.3
H1RKO 55/56 15.7±0.4 32.1±1.4 2.1±0.1 3.0±0.1
H1RKO-TgS 24/24 12.9±0.4 50.0±3.7 2.8±0.2 3.6±0.2
H1RKO-TgR 16/17 13.3±0.3 28.6±2.3 1.7±0.1 2.4±0.2
χ2 = 2.5 F = 13.5 21.2 19.2 14.4
p = 0.5 p < 0.0001 < 0.0001 < 0.0001 < 0.0001
C57BL/6J = H1RKO-TgS ≠ H1RKO-TgR= H1RKO
(b)
Strain Incidence DO CDS SI PS
C57BL/6J 18/18 16.6±0.7 37.6±2.9 2.6±0.1 3.2±0.2
H1RKO 26/33 17.1±0.5 20.0±1.8 1.6±0.1 2.2±0.1
H1RKO-TgS 22/23 16.2±0.6 36.4±3.8 2.5±0.2 3.2±0.2
H1RKO-TgR 13/14 18.7±0.6 18.6±3.1 1.6±0.2 1.9±0.2
χ2 = 7.4 F = 2.8 11.6 15.2 14.0
p = 0.06 p = 0.05 < 0.0001 < 0.0001 < 0.0001
C57BL/6J = H1RKO-TgS ≠ H1RKO-TgR= H1RKO